Ramya Bachu

Researcher

UAMS

Also affiliated: Indiana University Health (2020); Centre for Addiction and Mental Health (2018); Providence College (2019); Liaquat National Hospital (2018); Manhattan Psychiatric Center (2018); The University of Texas Rio Grande Valley (2018); Providence Hospital (2018–2019); St. Elizabeth's Medical Center (2018); Griffin Hospital (2019); Arkansas Baptist College (2023); Baptist Health Foundation (2019–2023); Winthrop Rockefeller Foundation (2023–2025); Zucker Hillside Hospital (2018–2019); Indiana University – Purdue University Indianapolis (2020); The University of Texas Health Science Center at Houston (2020)

Faculty Researcher

9 h-index 29 pubs 1,295 cited

Research Areas

Biomedical Subjects

Links

Research Group

OverviewAI-generated summary

Ramya Bachu's research focuses on the treatment and management of multiple myeloma, a hematologic malignancy. Her work investigates novel therapeutic strategies, including adoptive immunotherapy with chimeric antigen receptor (CAR) T-cell therapy targeting B-cell maturation antigen (BCMA). Bachu's publications explore methods to mitigate adverse effects associated with CAR T-cell therapy, such as immune effector cell-associated hematotoxicity, and the potential benefits of autologous stem cell boosts. She also examines the psychological impact of precursor conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma on patients. Additional research areas include less common presentations of multiple myeloma, such as sixth nerve palsy, and rare conditions like calciphylaxis in end-stage renal disease. Bachu has authored 29 publications with over 1,200 citations and an h-index of 9. She collaborates with colleagues at the University of Arkansas for Medical Sciences, including Tanvi H Patel and Trilok Shrivastava.

Metrics

h-index: 9
Publications: 29
Citations: 1,295

Selected Publications

Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma (2025)

Frontiers in Hematology 1 citation DOI OpenAlex
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)

Blood DOI OpenAlex
Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM) (2024)

Blood 2 citations DOI OpenAlex
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2024)

Clinical Hematology International 12 citations DOI OpenAlex
Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. (2024)

Journal of Clinical Oncology 2 citations DOI OpenAlex
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma (2024)

Bone Marrow Transplantation 25 citations DOI OpenAlex
A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma (2024)

Transplantation and Cellular Therapy 1 citation DOI OpenAlex
Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm (2024)

Cureus DOI OpenAlex
The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma (2023)

Blood 1 citation DOI OpenAlex
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2023)

Blood DOI OpenAlex
Necrotizing Enterocolitis in a Patient With Newly Diagnosed Multiple Myeloma and Hyperviscosity Syndrome: A Case Report (2023)

Cureus 1 citation DOI OpenAlex
Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023)

Cureus 2 citations DOI OpenAlex
Calciphylaxis in End-Stage Renal Disease: A Rare Condition With High Mortality (2022)

Cureus 2 citations DOI OpenAlex
Cerebral Venous Thrombosis Presenting as a Subacute Headache in a Young Man With Undiagnosed Factor V Leiden Mutation (2021)

Cureus 2 citations DOI OpenAlex
New Delhi Metallo-beta-lactamase-producing Enterobacter Cloacae – A Rare Multidrug Resistance Strain in a Caucasian Woman (2020)

Cureus 4 citations DOI OpenAlex